BCL2 and cancer: Yeast-injection IT (100 μl) for 16 weeks at concentrations of 107, 108, and 109 cells/ml caused apoptosis of cancer cells in a dose-dependent manner via modulation of the level of the Bcl-2 family, downregulating FasL levels, and activation of caspases.